Cancer cells overexpress the programmed death-ligand 1 (PD-L1), which binds to the programmed death-1 receptor (PD-1 or CD274) on activated T cells delivering an inhibitory signal to cytotoxic T lymphocytes that prevents tumor elimination from the immune system [5]. This evidence concerns the gene CD274 and neoplasm.